Article History
Received: 17 May 2017
Accepted: 28 January 2018
First Online: 26 February 2018
Ethics approval and consent to participate
: Data presented regarding LaserACE were obtained from IRB monitored and registered international clinical pilot studies (Trial Registration: NCT01491360), which followed the tenets of the Declaration of Helsinki.
: The LaserACE patients provided written consent for imaging and release of personal identifying information including medical record details.
: AMH reports personal fees and non-financial support from Ace Vision Group Inc. during the conduct of the study. In addition, Dr. Hipsley has a patent 7,871,404 issued to Ace Vision Group Inc., a patent 8,348,932 issued to Ace Vision Group, Inc., a patent 20,150,157,406 pending to Ace Vision Group, Inc., a patent 20,140,316,388 pending to Ace Vision Group, Inc., a patent 20,140,163,597 pending to Ace Vision Group, Inc., a patent 20,120,165,849 pending to Ace Vision Group, Inc., a patent 20,110,190,798 pending to Ace Vision Group, Inc., a patent 20,080,058,779 pending to Ace Vision Group, Inc., and a patent 20,070,016,175 pending to Ace Vision Group, Inc.BH reports personal fees from Ace Vision Group Inc. during the conduct of the study.